Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHC014748M in Relapsed/Refractory FL or MZL
NCT04431089Phase 2Unknown
- Sponsor
- Nanjing Sanhome Pharmaceutical Co., Ltd.
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of shc014748m in follicular lymphoma (FL), marginal zone lymphoma (MZL), sponsored by Nanjing Sanhome Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
shc014748m
03
Conditions
follicular lymphoma (FL)marginal zone lymphoma (MZL)
Beyond the preview
Go deeper on NCT04431089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04431089.